期刊文献+

卡瓦胡椒素B对人非小细胞肺癌A549细胞的抑制作用 被引量:3

Inhibitory Effect of Flavokawain B on Human Non-small Cell Lung Cancer A549 Cells
原文传递
导出
摘要 卡瓦胡椒素B是药用植物卡瓦胡椒根中的一种天然查耳酮类化合物,研究了其对人非小细胞肺癌A549细胞的增殖抑制作用及其诱导细胞凋亡的分子机制.实验结果显示,卡瓦胡椒素B能显著抑制非小细胞肺癌A549细胞的增殖,且随着药物浓度的增加、处理时间的延长其抑制作用呈明显的剂量时间效应;同时,卡瓦胡椒素B能显著诱导A549细胞凋亡、细胞周期阻滞于G2-M期;分子机制研究表明,卡瓦胡椒素B能通过活化JNK激酶活性、下调凋亡抑制蛋白survivin的表达以及激活PARP活性从而导致其对A549细胞的增殖抑制作用.结果表明卡瓦胡椒素B对人非小细胞肺癌的预防与治疗可能具有潜在价值. The anti-lung tumor potential of flavokawain B,one of active chalcones isolated from Kawa was investigated.Flavokawain B’s action was assessed on proliferation,apoptosis,cell cycle and molecular mechanisms in human non-small cell lung cancer(NSCLC) A549 cells in vitro.The results demonstrated that flavokawain B significantly inhibited the growth of A549 cells in a dose-and time-dependent manner.Meanwhile,flavokawain B induced cell apoptosis and cell cycle G2-M phase arrest in A549 cells.Mechanistically,flavokawain B could activate JNK signaling pathway,down-regulate the expression of survivin protein,and activate the cleavage of PARP,leading to marked inhibitory effect on A549 cells.These findings suggest that flavokawain B may be a potential usefulness for preventing and treatment of NSCLC.
出处 《应用与环境生物学报》 CAS CSCD 北大核心 2012年第5期740-744,共5页 Chinese Journal of Applied and Environmental Biology
基金 国家自然科学基金项目(No.811730 95) 国家自然科学基金重大研究计划(No.91013006) 四川省国际合作计划(No.2011HH0012)资助~~
关键词 卡瓦胡椒素B 肺癌细胞A549 细胞增殖 细胞凋亡 SURVIVIN JNK Flavokawain B lung cancer A549 cells cell proliferation cell apoptosis survivin JNK
  • 相关文献

参考文献16

  • 1Hecht SS, Kassie F, Hatsukami DK. Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat Rev Cancer, 2009, 9 (7): 476-488.
  • 2Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin, 2004, 54 (3): 150-180.
  • 3Le Marchand L, Hankin JH, Bach F. An eco-logical study of diet and lung cancer in the South Pacific, lnt J Cancer, I995, 63:18-23.
  • 4Steiner GG. The correlation between cancer inci-dence and kava consumption. Hawaii MedJ, 2000, 59:420-422.
  • 5Zi X, Simoneau AR. Flavokawain A, a novclchalcone from kava extract, induces apoptosis in bladder cancer cells by involvementof Bax protein-dependent and mitochondria-dcpendent apoptotic pathway and suppresses tumor growth in mice. Cam'er Res. 2005, 65:3479-3786.
  • 6Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prevention Res, 2()08, I (6): 439-451.
  • 7Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. Flavokawain B, a kava chalcone, exhibits robust apoptotic mechanisnas on androgen receptor- negative, hormone-refractory prostate cancer cell lines and reduces tumor growth in a preclinical model, lntern .l Cancer, 2010, 127 (8) 758-1768.
  • 8Zhao X, Chao Y, Wan Q, Chen X, Su E Sun J, Tang Y. Flavokawain ,q nduces apoptosis of human oral adenoid cystic up-regulation of Bim and down-regulation of Bc J Physiol & Pharmacol, 2011, 89 (12): 875-882 cancer ACC-2 cells via -2 gene expression. Can.
  • 9Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prevention Res, 2008, 1 (6): 439-451.
  • 10Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. Flavokawain B, a kava chalcone, exhibits robust apoptotic mechanisms on androgen receptor- negative, hormone-refractory prostate cancer ceil lines and reduces tumor growth in a preclinical model. Intern J Cance-, 2010, 127 (8): 1758-1768.

二级参考文献21

  • 1曹沛,吴凤锷,丁立生.银莲花属植物的化学及药理研究概况[J].天然产物研究与开发,2004,16(6):581-584. 被引量:22
  • 2廖循,李伯刚,高小平,官家发,丁立生,陈耀祖.西南银莲花的活性三萜皂苷[J].中草药,2001,32(6):493-496. 被引量:26
  • 3Cohen V, Khuri FR. Chemoprevention of lung cancer. Curr Opin Pulm Med, 2004, 10 (4): 279-283.
  • 4Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin, 2004, 54 (3): 150-180.
  • 5Naithani R, Huma LC, Moriarty RM, McCormick DL, Mehta RG. Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials. Curr Med Chem, 2008, 15 (11): 1044-1071.
  • 6Agarwal R, Deep G. Kava, a tonic for relieving the irrational development of natural preventive agents. Cancer Prev Res, 2008, 1 (6): 409-412.
  • 7RenFZ(任风芝) ZhangXX(张雪霞) NiuGY(牛桂云) ZhangL(张丽) ShanBE(单保恩) LiuGC(刘刚叁).Active antitumor constituents from Anemone raddeana Regel[J].中草药,2005,36(12):1975-1978.
  • 8Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prevention Res, 2008, 1 (6): 439-451.
  • 9Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. Flavokawain B, a kava chalcone, exhibits robust apoptotic mechanisms on androgen receptor-negative, hormone-refractory prostate cancer cell lines and reduces tumor growth in a preclinical model. Intern J Cancer, 2010, 127 (8): 1758-1768.
  • 10Tang Y, Simoneau AR, Liao W, Guo Y, Hoang BH, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Zi X. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Therapeutics, 2009, 8 (2): 458-468.

共引文献14

同被引文献25

  • 1Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancerstatistics [J]. CA Cancer J Clin, 2011, 61 (2): 69-90.
  • 2Aiyelaagbe OO, Hamid AA, Fattorusso E, Taglialatela-Scafati O,Schroder HC, Muller W. Cytotoxic activity of crude extracts as well asof pure components from Jatropha species, plants used extensively inAfrican traditional medicine [J]. Evid Based Complement Alternat Med,2011,2011: 134954.
  • 3Muangman S, Thippomwong M, Tohtong R. Anti-metastatic effects ofcurcusone B, a diterpene from Jatropha curcas [J]. In Vivo,2005,19 (1):265-268.
  • 4Zhang XL, Li F, Zhao ZG,Liu XL, Tang YX, Wang MK. Diterpenoidsfrom the root bark of Jatropha curcas and their cytotoxic activities [J],Phytochem Lett, 2012,5 (4): 721-724.
  • 5Tang Y, Simoneau AR, Xie J,Shahandeh B, Zi X. Effects of the kavachalcome flavokawain A differ in ovarian cancer cells with wild-typeversus mutant p53 [J]. Cancer Prev Res, 2008,1 (6): 439-451.
  • 6Tang Y,Simoneau AR, Liao WX, Yi G, Hope C, Liu F,Li S, Xie J,Holcombe RF,Jurnak FA, Mercola D, Hoang BH, Zi X. WIFI, a Wntpathway inhibitor, regulates SKP2 and c-myc expression leading to G1arrest and growth inhibition of human invasive urinary ovarian cancercells [J]. Mol Cancer Ther, 2009,8 (2): 458-468.
  • 7Tang Y, Li X, Simoneau AR, Xie J. Flavokawain B, a kava chalcone,exhibites robust apoptotic mechanisms on androgen receptor-negative,hormone-refractory prostate cancer cell lines and reduces tumor growthin a preclinical model [J]. Intern J Cancer, 2010,127 (8): 1758-1768.
  • 8Tang Y, Parmakhtiar B, Simoneau AR, Xie J, Fruehauf J,Lilly M, ZiX. Lycopene enhances docetaxel’s effect in castration-resistant prostatecancer associated with insulin-like growth factor I receptor levels [J].Neoplasia, 2011,13 (2): 108-119.
  • 9Chawla-Sarkar M,Lindner DJ, Liu YF,Williams BR,Sen GC,Silverman RH, Borden EC. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis [J]. Apoptosis, 2003,8: 237-249.
  • 10Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis(IAPs) as cancer targets [J]. Apoptosis, 2007,12 (9): 1543-68.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部